Industry News

The 700,000-square-foot, multi-site project is part of the company’s broader effort to expand domestic production capacity and strengthen U.S. pharmaceutical supply chains.

The agreement focuses on integrating ambient temperature biosample preservation with advanced 3D organoid models to support preclinical research and biotech developers.

The partnership aims to strengthen global peptide supply chains amid rising demand for metabolic disease therapies.

The deal shifts ownership of the Ballymurray manufacturing site while maintaining product supply continuity for the UK and Ireland markets.

The consortium aims to expand access to microbubble-based cell separation for cell therapy manufacturing.

The project adds large-scale GMP packaging, labeling, and cold chain capacity to support growing demand for pharmaceutical supply chain services.

The alliance connects early development expertise with commercial-scale OSD manufacturing for a single path from formulation to market.

The agreement reportedly will strengthen both companies’ sterile drug product manufacturing portfolios through the integration of fill-finish and packaging technologies.

The new operation replaces CSL Seqirus’ egg-based manufacturing facility and boosts capacity for seasonal and pandemic influenza response.

Investment will support the expansion of commercial operations, integration of additional units, and development of manufacturing infrastructure.

The collaboration centers on a digital twin system built to improve predictability and efficiency in large-scale monoclonal antibody production.

A renewed agreement with Monash University Malaysia aims to expand research capacity for proteomics, metabolomics, and biotechnology in the region.

Terumo Blood and Cell Technologies and The Blood Center in New Orleans look to transform the platelet processing landscape.

The multi-year agreement provides access to Intrepid’s machine learning platform to support early-stage formulation decisions.

The CDMO-CRO collaboration aims to accelerate advanced therapy programs from early development to commercialization.

The agreement supports regional biomanufacturing expansion and advances Qatar’s plans to grow its biopharmaceutical ecosystem.

The CDMO has teamed with the CRO to help drug developers increase yields and shorten the time to clinical trials.

The CDMO and CRDO will integrate formulation, analytical, and manufacturing expertise to provide support for end-to-end product development.

The company opened a new site in India and expanded facilities in Korea and Singapore to support biologics, vaccine, and cell and gene therapy biomanufacturing.

The collaboration aims to create faster and more effective routes to clinical trial readiness and beyond for cell and gene therapies.

John Murphy III, president and CEO of the Association for Accessible Medicines, unpacks what’s working, what’s not, and what must change for U.S. generic drug production.

The companies initiated Process Performance Qualification for a therapeutic that targets mortality and gastrointestinal injury in premature infants.

The new center will help biopharma companies reduce development risks and meet regulatory standards for novel biologics and biosimilars.

The dedicated micronization facility in Monteggio is Microsize’s second acquisition from Lonza, following the 2022 divestment of its Quakertown, Pennsylvania site.

Infrastructure for PharmaGuard and a unit for the regranulation of production-related plastic waste will be built on the grounds of its logistics center in Erolzheim.

The partnership will introduce efficient ABB motors to help GSK achieve its 2045 net-zero goals.

The joint effort will develop lipid-based microbubble technology as an alternative to magnetic beads for cell selection.

The companies will co-develop, scale up, and manufacture high-value APIs through a unified development-to-commercialization pathway.

The partnership combines platform innovation and cGMP expertise aimed at overcoming bottlenecks in mesenchymal stem cell expansion.

The pharmaceutical development and manufacturing organization’s expansion to support clinical trials marks 10 years of operations in the Asian country.